The influence of 4-hydroxy-4-androstene-3,17-dione on androgen metabolism and action in cultured human foreskin fibroblasts
- PMID: 3821101
- DOI: 10.1016/0022-4731(87)90041-0
The influence of 4-hydroxy-4-androstene-3,17-dione on androgen metabolism and action in cultured human foreskin fibroblasts
Abstract
4-hydroxy-4-androstene-3,17-dione (4-OHA) has been shown to be a potent inhibitor of aromatase activity. It is effective in the control of estrogen-dependent processes in female subjects and may potentially be useful in the treatment of estrogen-dependent processes in men. Human foreskin fibroblasts grown in cell culture provide a model to investigate the effects of 4-OHA on extraglandular aromatase activity as well as the ability of the compound to influence androgen receptor binding and the 5 alpha-reduction of testosterone (T). Initial experiments were carried out to determine the potency of 4-OHA in genital skin fibroblasts by incubating cells with 4-OHA over a range of concentrations. When aromatase activity was determined at a substrate concentration close to the apparent Km of the enzyme, a 44% inhibition of enzyme activity occurred at a mean concentration of 5 nM 4-OHA. Enzyme kinetic studies analyzed by Eadie-Hofstee plots demonstrated competitive inhibition by 4-OHA with a mean apparent Ki of 2.7 nM. When 5 alpha-reductase activity was determined in the presence of 200 nM [3H]T, in the absence or presence of 4-OHA, a 50% inhibition of enzyme activity occurred at an inhibitor concentration of 3 microM. In androgen receptor binding studies, 4-OHA possessed 1% of the affinity of dihydrotestosterone (DHT) for [3H]DHT binding sites. In summary: 4-OHA is a potent and specific inhibitor of aromatase activity in human genital skin fibroblasts, the affinity of the enzyme for 4-OHA being greater than its affinity for the substrate, androstenedione. The influence of 4-OHA on 5 alpha-reductase activity and androgen receptor binding is minimal.
Similar articles
-
Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.J Steroid Biochem. 1987 Aug;28(2):139-45. doi: 10.1016/0022-4731(87)90369-4. J Steroid Biochem. 1987. PMID: 3626551
-
Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.Cancer Lett. 1996 Mar 29;101(2):143-8. doi: 10.1016/0304-3835(96)04127-4. Cancer Lett. 1996. PMID: 8620462
-
Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.Cancer Res. 1989 Dec 1;49(23):6551-5. Cancer Res. 1989. PMID: 2479464
-
Exemestane (FCE 24304), a new steroidal aromatase inhibitor.J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):137-43. doi: 10.1016/0960-0760(92)90198-r. J Steroid Biochem Mol Biol. 1992. PMID: 1525055 Review.
-
Cultured human skin fibroblasts: a model for the study of androgen action.Mol Cell Biochem. 1981 Apr 13;36(1):3-22. doi: 10.1007/BF02354827. Mol Cell Biochem. 1981. PMID: 7017379 Review.
Cited by
-
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.Drugs. 1993 Jan;45(1):66-84. doi: 10.2165/00003495-199345010-00007. Drugs. 1993. PMID: 7680986 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources